肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

MicroRNA-140-5p通过靶向VEGF-A抑制乳腺癌的侵袭和血管生成

MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer

原文发布日期:2017-07-28 

英文摘要:

摘要翻译: 

原文链接:

文章:

MicroRNA-140-5p通过靶向VEGF-A抑制乳腺癌的侵袭和血管生成

MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer

原文发布日期:2017-07-28 

英文摘要:

MicroRNAs (miRNAs) have been proven to be involved in cell metastasis and angiogenesis by interaction with the target mRNAs. Evidence has been confirmed that miR-140-5p is a tumor suppressor in human cancers such as breast cancer. However, the potential molecular mechanism of miR-140-5p in breast cancer invasion and angiogenesis is still poorly understood. According to our study, we reported that miR-140-5p inhibited the tumor invasion and angiogenesis of breast cancer cells both in vitro and in vivo by targeting VEGF-A. The mRNA amount of miR-140-5p was decreased in the breast cancer clinical samples and breast cancer with metastasis compared with the corresponding adjacent normal tissues and cancer without metastasis. MiR-140-5p mimics and a negative control were transfected into human MCF-7 and MDA-MB-231 cells. Transwell chambers were used to detect the invasive ability of the cells, and the angiogenic ability was assessed by tube-formation assay. The markers of invasion and angiogenesis, VEGF-A, CD31 and MMP-9, were detected by using immunohistochemistry and western blot analysis in vivo. VEGF-A was verified as a possible target gene of miR-140-5p, and corroborated by dual-luciferase reporter and ELISA. Taken together, the study elucidates the molecular mechanisms by which miR-140-5p inhibits breast cancer metastasis and angiogenesis, and provides a potent evidence for the development of a novel microRNA-targeting anticancer strategy for breast cancer patients. 

摘要翻译: 

MicroRNAs(miRNAs)已被证实通过与其靶向mRNAs的相互作用参与细胞转移和血管生成过程。现有证据表明,miR-140-5p在乳腺癌等多种人类癌症中具有肿瘤抑制功能。然而,miR-140-5p在乳腺癌侵袭和血管生成中的潜在分子机制尚不明确。本研究通过实验证实:miR-140-5p通过靶向VEGF-A,在体外和体内实验中均能抑制乳腺癌细胞的肿瘤侵袭和血管生成。在乳腺癌临床样本及发生转移的乳腺癌组织中,miR-140-5p的mRNA表达量较对应癌旁正常组织及未转移癌组织显著降低。我们将miR-140-5p模拟物和阴性对照分别转染至人MCF-7和MDA-MB-231细胞系,采用Transwell小室检测细胞侵袭能力,并通过血管形成实验评估血管生成能力。在体内实验中,通过免疫组化和蛋白质印迹法检测了侵袭与血管生成标志物VEGF-A、CD31及MMP-9的表达水平。双荧光素酶报告基因实验和ELISA检测共同验证VEGF-A是miR-140-5p的潜在靶基因。本研究系统阐明了miR-140-5p抑制乳腺癌转移和血管生成的分子机制,为开发针对乳腺癌患者的microRNA靶向抗癌策略提供了有力依据。

原文链接:

MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……